Company Profile
Synlogic Stock Price, News & Analysis
- Ticker:
- SYBX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.67 USD (-5.80%)
Close
Last updated: July 23, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for SYBX.
Company overview
Business overview
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ before restructuring, Synlogic sat in synthetic biology and biotechnology.
Business Model Characteristics
The company depended on platform validation, clinical proof, and the ability to turn engineered-microbe science into value.
Position Within the Biotechnology Landscape
Synlogic belongs to the historical synthetic-biology category rather than the current live public-company set.
Future catalysts
Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is mainly waiting for clarity on what value, if any, remains.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Enlivex Announces $400,000,000 Private Placement
ENLV · Source: Enlivex Therapeutics
- 02
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
MLYS · Source: Mineralys Therapeutics
- 03
- 04
Viking Therapeutics Appoints Dorothy Gemmell to Board of Directors
VKTX · Source: Viking Therapeutics
- 05
Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026
VKTX · Source: Viking Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Synlogic (SYBX)?
Synlogic (SYBX) most recently closed at 0.67 USD, a -5.80% move versus the previous session.
What does Synlogic do?
Synlogic was a synthetic-biology company focused on engineered microbes and metabolic disease before its restructuring and decline. Its platform aimed to use living medicines to address rare disorders.
On which exchange is SYBX stock listed?
Synlogic (SYBX) is associated with NASDAQ, United States, Biopharma.
What is Synlogic?
Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.
Which conditions is Synlogic targeting with Synlogic?
Synlogic is associated with metabolic disease based on its company overview and current catalyst commentary.
How does Synlogic describe recent progress with Synlogic?
Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone.
What future catalysts are investors watching for Synlogic?
Synlogic is now mostly a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is mainly waiting for clarity on what value, if any, remains.